| Normally, when most people hear ' 3D printing 'Is the first thing that comes to mind when it comes to fully 3D printed human organs.The idea of being able to transplant the required organs into the patient without having to wait for donated organs is a very exciting prospect, especially since the idea is Using a patient's own stem cells to form a 3D printed organism means less risk of rejection, but significant advances have been made in the development of the 3D printed vascular network and skin, as well as the transplants of 3D-printed ovaries and thyroid into mice At the same time, in the next few years, we may not see 3D printed implantable human organs.  But 3D-printed organs are not the only innovations that biological 3D printing can do - 3D printed living tissue can be used to save lives in the form of heart patches, and special polymer inks can help create organ-on-chip 3D Printed flexible electronics may be a pioneer in soft power biology for implantable health monitors. Bio-3D printing can also be used to create strong drug-tested tumors, giving scientists another very useful technical application: drug testing and development. 3D printing technology It can be used to evaluate new drugs and get them to market faster, eliminating the need for animal testing as an added benefit. Historically, many drugs have been discovered by chance - scientist Alexander Fleming discovered that a Staphylococcus aureus petri dish was accidentally missed and contaminated by window-opening molds or by identifying active ingredients from traditional medicines Penicillin In the modern world of biotechnology, medicine and pharmacology, we call it the process of drug discovery and design of drug discovery. RegenHU, a Swiss biometric 3D printing technology company, has developed biomedical products for drug discovery and regenerative medicine using the potential of cell therapy and bio-3D printing. The company has an impressive lineup of bio-3D printers whose bioprinting Suitable for microfluidics, chip labs, personalized medicine and drug screening and development, the solution recently named Wako Automation, a laboratory automation solution provider based in San Diego, as its official systems integrator in the United States. Marc Thurner, CEO of regenHU, said: 'The synergy of our expertise provides leading pharmaceutical and biotech innovators with a unique value solution that allows us to personalize the specific needs of each developer.' Several recent advances have been made in the field of biological 3D printing, which provide important tools in the fabrication of biomimetic tissue structures that can later be applied to different phases of drug development RegenHU uses its bio-printing and bio-manufacturing solutions to drive New clinical products and solutions to support the scientific community, working together with Wako Automation and RegenHU to promote the development of biomedical 3D printing in the United States and to integrate biologic 3D printing solutions into existing automated drug discovery systems in. Robert Bukar, Director of Business Development at Wako Automation, said: "The partnership with RegenHU will enable our customers in the forefront of drug development to fully integrate RegenHU's bio-3D printers into state-of-the-art drug discovery systems." Wako Automation specializes in laboratory automation and high-content imaging; in addition, it is the leading distributor of Yokogawa's CV8000, whose customers regard additive manufacturing and microscopy as the two most important components of their drug discovery and discovery process section. Next month, at the SLAS conference in San Diego, RegenHU and Wako Automation will showcase their respective technologies at booth 1002 and show potential clients how they can help upgrade existing biomedical solutions. Source: 3D Tiger |
 |
|